Search Within

Michael Scordo

Formats
  1. Meeting Abstract (250)
  2. Journal Article (104)
  3. Research Letter (15)
  4. Correspondence (7)
  5. Editorial (5)
  6. Review (4)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Bone Marrow Transplant (387)
  2. CTCR Scholars (387)
  3. Center for Hematologic Malignancies (387)
  4. Department of Medicine (387)
  5. Hematologic Malignancies, Division of (387)
  6. Survivorship Research (338)

More Groups

People
  1. Gunjan Shah (298)
  2. Sergio Giralt (278)
  3. Miguel-Angel Perales (177)
  4. Sean Devlin (152)
  5. Heather Landau (141)
  6. Parastoo Dahi (140)

More People

Years
  1. 2025 (22)
  2. 2024 (72)
  3. 2023 (81)
  4. 2022 (49)
  5. 2021 (27)
  6. 2020 (53)

More Years

Publications
  1. Blood (123)
  2. Biology of Blood and Marrow Transplantation (56)
  3. Clinical Lymphoma, Myeloma and Leukemia (36)
  4. Bone Marrow Transplantation (26)
  5. Blood Advances (21)
  6. Transplantation and Cellular Therapy (15)

More Publications

Publishers
  1. American Society of Hematology (144)
  2. Elsevier Inc. (122)
  3. Nature Publishing Group (40)
  4. American Society of Clinical Oncology (14)
  5. Wiley Blackwell (9)
  6. Oxford University Press (7)

More Publishers

Results (387)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world experience
    Meeting Abstract

    Hultcrantz, M.; Orozco, J.; Peterson, T. J.; Derkach, A.; Hassoun, H.; Korde, N.; Lu, S. X.; Mailankody, S.; Patel, D.; Shah, U. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Successful incorporation of electronic patient-reported outcomes using PROMIS-29 into standard of care for lymphoma patients receiving CD19-directed chimeric antigen receptor T (CAR T) cell therapy
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Sauter, C.; Batlevi, C.; Dahi, P. B.; Lin, R.; Palomba, M. L.; Perales, M. A.; Giralt, S. A.
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Daratumumab, carfilzomib, lenalidomide, & dexamethasone for relapsed/refractory myeloma with salvage autologous hematopoietic cell transplant: Interim analysis of the multicenter 2nd chance protocol
    Meeting Abstract

    Shah, G.; Bal, S.; Rodriguez, C.; Chhabra, S.; Bayer, R.; Costa, L.; Lambird, J.; Ferrer, C.; Parascondola, A.; Marcello, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets
    Meeting Abstract

    Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
    Journal Article

    Zuanelli Brambilla, C.; Lobaugh, S. M.; Ruiz, J. D.; Dahi, P. B.; Goldberg, A. D.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Acute kidney injury in the modern era of allogeneic hematopoietic stem cell transplantation
    Journal Article

    Abramson, M. H.; Gutgarts, V.; Zheng, J.; Maloy, M. A.; Ruiz, J. D.; Scordo, M.; Jaimes, E. A.; Sathick, I. J.
    Clinical Journal of the American Society of Nephrology (2021)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Recommendations for testing and treating outpatient cancer patients in the era of COVID-19
    Guidelines

    Reidy-Lagunes, D.; Saltz, L.; Postow, M.; Scordo, M.; Moskowitz, A.; Tew, W.; Zamarin, D.; Redelman-Sidi, G.
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Open label dose escalation trial of AB-205 (E-CEL® cells) in adults with systemic lymphoma undergoing high-dose therapy and autologous hematopoietic cell transplantation (HDT-AHCT)
    Meeting Abstract

    Mulroney, C.; Scordo, M.; Abedi, M.; Budde, L. E.; Fakhri, B.; Pawarode, A.; Dholaria, B.; Shouse, G.; Kavalerchik, E.; Aggarwal, S.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Microbiota injury is conditioning regimen-dependent in allogeneic hematopoietic cell transplantation recipients
    Meeting Abstract

    Shouval, R.; Gomes, A.; Nguyen, C.; Markey, K. A.; Dai, A.; Zuanelli Brambilla, C.; Taur, Y.; Scordo, M.; Giralt, S. A.; Perales, M. A.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save